Abstract
Background Segregation of unvaccinated people from public spaces has been a novel and controversial COVID-era public health practice in many countries. Models have been used to explore potential epidemiological impacts of vaccination-status-based segregation, however existing models do not realistically represent the segregation because they neglect its effect on decreasing or increasing the contact frequencies of the segregated individuals. We systematically investigate how including the effect of segregation on contact frequencies changes predicted epidemiological outcomes.
Methods We describe a susceptible-infectious-recovered (SIR) two-population model for vaccinated and unvaccinated groups of individuals that transmit an infectious disease by pairwise person-to-person contact. The degree of segregation between the two groups, ranging from no segregation to complete segregation, is implemented using the like-to-like mixing approach developed by Garnett and Anderson (1996) for sexually transmitted diseases and recently applied to SARS-CoV-2 transmission and vaccination (Fisman et al., 2022). The model allows the contact frequencies for individuals in the two groups to be different and to depend, with variable strength, on the degree of segregation.
Results Model predictions for a broad range of model assumptions and respiratory-disease epidemiological parameters are calculated to examine the effects of segregation. Segregation can either increase or decrease the attack rate among the vaccinated, depending on the type of segregation (whether isolating or compounding), and on the contagiousness of the disease. For diseases with relatively low contagiousness, segregation can cause an attack rate in the vaccinated, which does not occur without segregation.
Interpretation There is no blanket epidemiological advantage to implementing segregation, either for the vaccinated or the unvaccinated. Negative epidemiological consequences can occur for both groups.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This is a modeling paper, therefore all data is from simulations. Information for reproducing the simulations is contained in the manuscript and appendices.